COMMUNIQUÉS West-GlobeNewswire

UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening System
18/01/2024
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico
18/01/2024
BASKING RIDGE, NJ, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]
Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital
18/01/2024
Cash infusion to provide company with additional resources for accelerated growth PALM BEACH GARDENS, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Accelus , a privately held medical technology company committed to becoming [...]
Panbela Announces Publication of Clinical Data Titled: Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
18/01/2024
A Phase 1 clinical study showed that high dose DFMO treatment in combination with chemotherapy may provide therapeutic benefits to heavily pretreated patients with neuroblastoma. MINNEAPOLIS, Jan. 18, 2024 (GLOBE [...]
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
18/01/2024
LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
18/01/2024
CAPE CANAVERAL, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of medicines, today announced a collaboration with the University of [...]
Canadian Men’s Health Foundation reports that more men are addressing stress, anxiety and depression
18/01/2024
Use of the MindFit Toolkit supported a 13x increase in counselling services completed at no-cost last year with continued growth expected in 2024 VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The [...]
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
18/01/2024
Call scheduled for Monday, February 12th at 4:30 pm Eastern Time GARDEN CITY, N.Y., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device [...]
LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference
18/01/2024
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Conference, being held [...]
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
18/01/2024
Dr. Frederick to advise Company on corporate affairs and commercial strategy for efzofitimod in interstitial lung disease (ILD). SAN DIEGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or “ [...]
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
18/01/2024
POMPANO BEACH, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to easing chronic pain without the use of opioids, and Sure Med Compliance, a digital healthcare company focused [...]
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
18/01/2024
PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies MARLBOROUGH, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial [...]
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
18/01/2024
Southlake, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology [...]
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio
18/01/2024
KRRO-110 has a potentially best-in-class profile with secretion of ~50µM functional AAT protein after a single dose in a preclinical mouse model Evidence of greater than 40% editing of SERPINA1 RNA in non-human primates [...]
Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain
18/01/2024
SAN FRANCISCO and BERLIN, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Reservoir Neuroscience announced today the completion of a $4M financing round to support the development of new therapies for age-related neurodegeneration. [...]
Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split
18/01/2024
HANOVER, MD, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of [...]
Genflow Biosciences Partners with Revatis SA and EXO Biologics in Groundbreaking Aging Research, Fueled by Two Major Research Grants
18/01/2024
LONDON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (Genflow or the "Company”) (LSE:GNF) (OTCQB:GENFF), an emerging leader in the field of longevity research developing therapeutics that potentially halt [...]
AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING
18/01/2024
CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal [...]
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
18/01/2024
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study BRAINTREE, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Microbot [...]

Pages